Viatris Archives - Page 2 of 3 - Express Pharma

Europe’s generic drug makers say they may cut output due to energy bills

Balancing profitability with sustainability

Biocon Biologics and Viatris launch Abevmy in Canada

Biocon Q4FY22 revenue at Rs 2,476 crores, up 21 per cent

Viatris in India now ‘Great Place to Work’-certified

Biocon Biologics to acquire Viatris’ biosimilars assets for up to $3.335 billion

Viatris wins US court decisions on Sanofi appeals for Lantus device patents

Biocon Biologics and Viatris launch interchangeable Semglee

Biocon Biologics and Viatris’s Semglee preferred on Express Scripts’ largest formulary in US

Approval of first interchangeable biosimilar insulin to increase competition with payer contracts: GlobalData